Blog Articles

ON THE HORIZON – INDIVIDUALIZED BIOMARKER DRIVEN THERAPY IN CASTRATE RESISTANT PROSTATE CANCER (CRPC) –

Dr. Eshaghian will update us on what is fact and what is fiction when treating high risk and/or metastatic PCa. Dr. Bob will update us on ‘Challenging Prostate Cancer Treatment Biases; Is Nothing Sacred?”

Watch Dr. Bob & Dr. Eshaghian’s latest lecture, titled “Our Three-Pronged Approach Protocol for treatment of high-risk metastatic and/or recurrent prostate cancer and results from hundreds of PC patients utilizing High-Dose Testosterone Replacement...

See the latest PAACT newsletter (March 2014) to read Dr. Bob’s article: “Challenging PC Treatment Biases – Is Nothing Sacred? – Part I”. This is part of a three issue series, starting with an article in the Winter 2013 issue of PAACT titled...

See the latest PAACT newsletter (Dec 2013) to read Dr. Bob’s article: “Dr. Bob’s treatments and insights regarding prostate cancer”. Click here to download a copy for free. For more information on PAACT...

Dr. Bob, Dr. Eshaghian and the COMG staff wishes all a Happy Hanukkah, Merry Christmas, and a Happy HEALTHY New Year and Year of the Horse.

Free community lecture on 5/9/2013! Dr. Bob and Dr. Eshaghian will be giving a talk at the Riverside Medical Clinic Foundation Prostate Cancer Family Support Group. Click here for a printable flyer: may9lectureflyer...

***New Feature***: You can now order our collection of DVD’s online. Visit our Video Lectures Page to see the list of DVD’s available by clicking here to order online or by calling us at (310) 229-3555.

Welcome Dr. Shahrooz Eshaghian to Compassionate Oncology Medical Group!

We are pleased to announce that Provenge®(sipuleucel-T), a breakthrough treatment for certain types of advanced prostate cancer, is now available at Compassionate Oncology Medical Group. Provenge is the first and only immunotherapy approved by the...